You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

galcanezumab

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine Trial in San Francisco (Galcanezumab)

Recruiting
  • Migraine
  • Galcanezumab
  • San Francisco, California
    University of California, San Francisco
Oct 10, 2023

Migraine Trial (Galcanezumab, Placebo)

Not yet recruiting
  • Migraine
  • Galcanezumab
  • Placebo
  • (no location specified)
Aug 5, 2022

Healthy Trial in Shanghai (Galcanezumab, Placebo)

Completed
Has Results
  • Healthy
  • Galcanezumab
  • Placebo
  • Shanghai, Shanghai, China
    HuaShan Hospital Affiliated To Fudan University
May 20, 2021

Safety, and Tolerability of GAlcanezumab in Real Life Migraine

Recruiting
  • Migraine
  • Galcanezumab
  • Rome, RM, Italy
    Campus Bio Medico University Hospital
Mar 16, 2021

Episodic Migraine Trial in China, India, Russian Federation (Galcanezumab, Placebo)

Completed
Has Results
  • Episodic Migraine
  • Galcanezumab
  • Placebo
  • Beijing, Beijing, China
  • +39 more
Jul 27, 2022

Migraine Trial in Los Angeles, Newport Beach, Waterbury (Galcanezumab, Erenumab)

Completed
Has Results
  • Migraine
  • Los Angeles, California
  • +2 more
Feb 23, 2022

Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

Recruiting
  • Migraine
  • +4 more
  • Innsbruck, Tirol, Austria
  • +2 more
Oct 19, 2022

Migraine Trial in Springfield, West Bend (Ubrogepant, Erenumab, Galcanezumab)

Completed
Has Results
  • Migraine
  • Springfield, Missouri
  • +1 more
Feb 17, 2021

CGRP Inhibition, Autonomic Function, and Migraine

Recruiting
  • Episodic Migraine
  • Chronic Migraine
  • Vienna, Austria
    Medical University of Vienna
Apr 8, 2022

Episodic Cluster Headache, Chronic Cluster Headache Trial in Worldwide (Galcanezumab)

Completed
Has Results
  • Episodic Cluster Headache
  • Chronic Cluster Headache
  • Galcanezumab
  • Phoenix, Arizona
  • +39 more
Jan 20, 2022

Migraine, Episodic Migraine Trial in United States (Galcanezumab, Placebo, Rimegepant)

Recruiting
  • Migraine
  • Episodic Migraine
  • Galcanezumab
  • +2 more
  • Gilbert, Arizona
  • +75 more
Jan 16, 2023

Chronic Migraine Trial in Worldwide (Galcanezumab, Placebo)

Recruiting
  • Chronic Migraine
  • Galcanezumab
  • Placebo
  • Huntsville, Alabama
  • +82 more
Dec 26, 2022

Migraine Trial in Ridgeland (Eptinezumab, Erenumab, Onabotulinumtoxin-A)

Recruiting
  • Migraine
  • Gilbert, Arizona
  • +9 more
Nov 9, 2022

Episodic Migraine Trial in Worldwide (Galcanezumab, Placebo)

Recruiting
  • Episodic Migraine
  • Galcanezumab
  • Placebo
  • Huntsville, Alabama
  • +76 more
Aug 17, 2022

Migraine Trial in Worldwide (Galcanezumab, Placebo)

Completed
Has Results
  • Migraine
  • Galcanezumab
  • Placebo
  • Phoenix, Arizona
  • +68 more
Jun 19, 2020

Migraine Trial in Japan (Galcanezumab, Placebo)

Completed
Has Results
  • Migraine
  • Galcanezumab
  • Placebo
  • Chiba, Japan
  • +46 more
Apr 1, 2021

Healthy Trial in Dallas (Galcanezumab, Placebo)

Completed
Has Results
  • Healthy
  • Galcanezumab
  • Placebo
  • Dallas, Texas
    Covance
Oct 19, 2018

Migraine Trial in Worldwide (Galcanezumab)

Completed
Has Results
  • Migraine
  • Galcanezumab
  • Santa Monica, California
  • +26 more
Jun 10, 2020

Migraine Trial in Japan (Galcanezumab)

Completed
Has Results
  • Migraine
  • Galcanezumab
  • Chofu-shi, Japan
  • +43 more
Sep 8, 2020

Migraine Trial in Worldwide (Galcanezumab, Placebo)

Completed
Has Results
  • Migraine
  • Galcanezumab
  • Placebo
  • Phoenix, Arizona
  • +112 more
Jun 10, 2020

Migraine Headache Trial in United States (Galcanezumab, Placebo)

Completed
Has Results
  • Migraine Headache
  • Galcanezumab
  • Placebo
  • Gilbert, Arizona
  • +39 more
Nov 20, 2018

Episodic Cluster Headache Trial in Worldwide (Galcanezumab, Placebo)

Completed
Has Results
  • Episodic Cluster Headache
  • Galcanezumab
  • Placebo
  • Los Angeles, California
  • +46 more
Aug 26, 2019